Company intelligence / Profile preview

RegenerAge

Mexico City, Ciudad de México, Mexicoregenerage.org.uk ↗

Ownership: Private
Development stage: Commercial

Overview

RegenerAge is an internationally recognized medical group and clinic network specializing in advanced regenerative medicine, offering cell-based therapies and biomedical engineering solutions for conditions such as stroke, post-COVID lung issues, anti-aging, brain injuries, and cerebral palsy. The company emphasizes patient testimonials of positive outcomes but does not publish formal clinical trial data on its website.

Therapeutic areas: PulmonologyDermatologyNeurology
Modalities: Cell therapyStem cell therapyBiomedical engineering solutions
Industry: Non-Academic Healthcare

Partnerships

Not explicitly listed. The company mentions collaborations with prominent organizations globally but does not specify names or details on the website.

Beyond the preview

Go deeper on RegenerAge.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RegenerAge.

Explore the full profile